Liege, Belgium, 20 May 2021 -18:45 CEST - Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health, is very pleased to announce that the European Commission has accepted the registration application for the novel combined oral contraceptive Estelle®. This decision follows the adoption of a positive opinion by the Committee for Medicinal Products for Human Use ('CHMP') of the European Medicines Agency ('EMA') on 26 March 2021 and is valid for all Member States of the European Union.

Attachments

  • Original document
  • Permalink

Disclaimer

Mithra Pharmaceuticals SA published this content on 20 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 May 2021 16:50:00 UTC.